Kennedy Capital Management’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-98,378
Closed -$10.5M 587
2025
Q3
$10.5M Sell
98,378
-10,672
-10% -$1.11M 0.23% 147
2025
Q2
$10.3M Sell
109,050
-27,498
-20% -$2.04M 0.25% 133
2025
Q1
$8.67M Sell
136,548
-209,555
-61% -$12.5M 0.21% 168
2024
Q4
$16.1M Sell
346,103
-12,344
-3% -$463K 0.36% 57
2024
Q3
$10.3M Buy
358,447
+20,912
+6% +$515K 0.23% 135
2024
Q2
$4.88M Buy
337,535
+214,320
+174% +$3.13M 0.1% 323
2024
Q1
$1.98M Sell
123,215
-42,442
-26% -$734K 0.04% 523
2023
Q4
$3.29M Buy
165,657
+26,056
+19% +$385K 0.07% 387
2023
Q3
$2.28M Buy
139,601
+22,529
+19% +$434K 0.06% 436
2023
Q2
$2.47M Buy
+117,072
New +$2.5M 0.06% 420

Other funds holding VRNA